Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Rakovina Therapeutics Inc. has announced a private placement offering, securing over $800,000 in initial commitments to advance their innovative cancer therapies. The funds will support the development of novel treatments using AI platforms, aiming for breakthroughs in DNA-damage response technologies.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
